Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2013; 19(45): 8398-8407
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8398
Figure 1
Figure 1 Kaplan-Meier survival analysis curve. A: The overall survival for patients with hepatocellular carcinoma undergoing liver transplantation classified by different neutrophil-lymphocyte ratios (NLRs); B: The disease-free survival for patients with hepatocellular carcinoma undergoing liver transplantation by different NLRs.
Figure 2
Figure 2 Receiver operating characteristic curve for the neutrophil-lymphocyte ratio cut-off value to predict tumor recurrence of hepatocellular carcinoma patients after liver transplantation.
Figure 3
Figure 3 Kaplan-Meier survival analysis curve. A: The overall survival for patients with hepatocellular carcinoma undergoing liver transplantation classified by the cut-off neutrophil-lymphocyte ratio (NLR) of 4; B: The disease-free survival for patients with hepatocellular carcinoma undergoing liver transplantation by the cut-off NLR of 4.